Alle Förderungen

Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (R24 Clinical Trial Not Allowed)

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)

Mechanistic Toxicology of METALS: Metal Exposure, Transport, Action, Localization, and Susceptibility (RP1 Clinical Trial Not Allowed)

Limited Competition: Tribal Institutional Review Board Establishment and Enhancement (TIRBEE)

Limited Competition: Tribal Undergraduate and Graduate Research Training and Leadership Experiences (TURTLE) Program

Emerging Global Leader Award (K43)

Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth)

Single Source: Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Data Resource and Administrative Coordination Center (U24 Clinical Trial Not Allowed)

Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs)

Technology Development Program

Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)

FY2026/2027 Community Compass Technical Assistance and Capacity Building Program Notice of Funding Opportunity

Research to Improve Rigor, Replicability, and Reproducibility in Biomedical and Behavioral Sciences

State Biomonitoring Cooperative Agreement

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)

Collaborative Centers in Children’s Environmental Health Research and Translation (P2C Clinical Trial Optional)

Immune Drivers of Autoimmune Disease